Logotipo do repositório

Effects of rivastigmine on the pathogenesis of the experimental trypanosomiasis

dc.contributor.authorRossi, Letícia Farto de
dc.contributor.authorGonçalves, Bárbara
dc.contributor.authorFrediani, Henrique
dc.contributor.authorChies, Agnaldo Bruno
dc.contributor.authorHataka, Alessandre [UNESP]
dc.contributor.authorRuiz, Marcelo
dc.contributor.authorBaleotti, Wilson
dc.contributor.authorDonadi, Eduardo Antonio
dc.contributor.authorMartins, Luciamáre Perinetti Alves
dc.date.accessioned2026-04-27T18:07:32Z
dc.date.issued2025-11-26
dc.description.abstractInflammation is important mechanism in Chagas disease (CD) pathogenesis. Considering that CD treatment presents a limited efficacy and anticholinesterase drugs may have antiinflamamtory properties, they could be used as a therapeutic option. We decided evaluate the action of rivastigmine on the anti-inflammatory cholinergic pathway during the course of CD. For this, 120 "Swiss" mice were divided into three groups: 30, 60 and 180 days, and subdivided into four subgroups: Uninfected/untreated (CTRL); uninfected/treated with rivastigmine (RIV); infected/treated (INF + RIV) and infected/untreated (INF). The INF + RIV and INF groups were intraperitoneally inoculated with 5 × 10<sup>4</sup> trypomastigote forms of Trypanosoma cruzi QM2 strain. Parasitemia, histopathological, GSH, FRAP, TBARS tissue, BChE, AChE and in silico analysis were determined. We observed a decrease in parasitemia and mortality in the animals of the INF + RIV group. The increase in GSH in the INF + RIV and INF groups indicated oxidative damage in the acute phase, nevertheless no significant difference was observed in FRAP, tissue and histopathological TBARS between the infected and control groups. An increase in BChE activity was observed in the INF + RIV and INF groups in all periods studied, yet, the AChE activity was lower in the INF and INF + RIV groups only at 60 days post-infection. In silico analysis revealed that AChE exerts a catalytic role on ACh through the catalytic triad (Ser<sup>200</sup>; HIS<sup>440</sup>; Glu<sup>327</sup>), rivastigmine being associated with the His<sup>440</sup> binding site. Rivastigmine reduced parasitemia and mortality in vivo in the acute phase of infection, suggesting a potential modulatory role on the non-neuronal cholinergic pathway, although further studies are required to understand it.
dc.description.abstractInflammation is important mechanism in Chagas disease (CD) pathogenesis. Considering that CD treatment presents a limited efficacy and anticholinesterase drugs may have antiinflamamtory properties, they could be used as a therapeutic option. We decided evaluate the action of rivastigmine on the anti-inflammatory cholinergic pathway during the course of CD. For this, 120 "Swiss" mice were divided into three groups: 30, 60 and 180 days, and subdivided into four subgroups: Uninfected/untreated (CTRL); uninfected/treated with rivastigmine (RIV); infected/treated (INF + RIV) and infected/untreated (INF). The INF + RIV and INF groups were intraperitoneally inoculated with 5 × 10<sup>4</sup> trypomastigote forms of Trypanosoma cruzi QM2 strain. Parasitemia, histopathological, GSH, FRAP, TBARS tissue, BChE, AChE and in silico analysis were determined. We observed a decrease in parasitemia and mortality in the animals of the INF + RIV group. The increase in GSH in the INF + RIV and INF groups indicated oxidative damage in the acute phase, nevertheless no significant difference was observed in FRAP, tissue and histopathological TBARS between the infected and control groups. An increase in BChE activity was observed in the INF + RIV and INF groups in all periods studied, yet, the AChE activity was lower in the INF and INF + RIV groups only at 60 days post-infection. In silico analysis revealed that AChE exerts a catalytic role on ACh through the catalytic triad (Ser<sup>200</sup>; HIS<sup>440</sup>; Glu<sup>327</sup>), rivastigmine being associated with the His<sup>440</sup> binding site. Rivastigmine reduced parasitemia and mortality in vivo in the acute phase of infection, suggesting a potential modulatory role on the non-neuronal cholinergic pathway, although further studies are required to understand it.
dc.description.affiliationHealth and Aging at the Famema, Marília Medical School, Marília, SP 17519-100, Brazil.
dc.description.affiliationFamema, Marília Medical School, Marília, SP 17519-100, Brazil.
dc.description.affiliationDepartment of Pharmacology, Marília Medical School, Marília, SP 17519-100, Brazil.
dc.description.affiliationDepartment of Veterinary Clinical Sciences, School of Veterinary Medicine and Animal Science, Sao Paulo State University (UNESP), Botucatu, SP 18618-687, Brazil.
dc.description.affiliationLaboratorio Diagnostico do Brasil (DB), Curutiba, Parana 80050-350, Brazil.
dc.description.affiliationDepartment of Clinical Pathology, Marília Medical School, Marília, SP 17519-030, Brazil.
dc.description.affiliationDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil.
dc.description.affiliationDepartment of Parasitology, Marília Medical School, Marília, SP 17519-100, Brazil. Electronic address: luciamarepam@gmail.com.
dc.description.affiliationLaboratorio Diagnostico do Brasil (DB), Curitiba, Parana 80050-350, Brazil.
dc.description.affiliationUnespDepartment of Veterinary Clinical Sciences, School of Veterinary Medicine and Animal Science, Sao Paulo State University (UNESP), Botucatu, SP 18618-687, Brazil.
dc.identifierhttps://app.dimensions.ai/details/publication/pub.1195449196
dc.identifier.dimensionspub.1195449196
dc.identifier.doi10.1016/j.parint.2025.103202
dc.identifier.issn1383-5769
dc.identifier.issn1873-0329
dc.identifier.orcid0000-0003-2793-1019
dc.identifier.orcid0000-0002-2023-212X
dc.identifier.orcid0000-0002-9457-9601
dc.identifier.orcid0000-0001-9263-2475
dc.identifier.orcid0000-0003-1442-7964
dc.identifier.pmid41314334
dc.identifier.urihttps://hdl.handle.net/11449/322742
dc.publisherElsevier
dc.relation.ispartofParasitology International; v. 112; p. 103202
dc.rights.accessRightsAcesso restritopt
dc.rights.sourceRightsclosed
dc.sourceDimensions
dc.titleEffects of rivastigmine on the pathogenesis of the experimental trypanosomiasis
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication9ca5a87b-0c83-43fa-b290-6f8a4202bf99
relation.isOrgUnitOfPublication.latestForDiscovery9ca5a87b-0c83-43fa-b290-6f8a4202bf99
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina Veterinária e Zootecnia, Botucatupt

Arquivos